BACKGROUND: Corpus callosum thickness measurement on mid-sagittal MRI may be a surrogate marker of brain volume. This is important for evaluation of diseases causing brain volume gain or loss, such as HIV-related brain disease and HIV encephalopathy. OBJECTIVE: To determine if thickness of the corpus callosum on mid-sagittal MRI is a surrogate marker of brain volume in children with HIV-related brain disease and in controls without HIV. MATERIALS AND METHODS: A retrospective MRI analysis in children (<5 years old) with HIV-related brain disease and controls used a custom-developed semi-automated tool, which divided the midline corpus callosum and measured its thickness in multiple locations. Brain volume was determined using volumetric analysis. Overall corpus callosum thickness and thickness of segments of the corpus callosum were correlated with overall and segmented (grey and white matter) brain volume. RESULTS: Forty-four children (33 HIV-infected patients and 11 controls) were included. Significant correlations included overall corpus callosum (mean) and total brain volume (P = 0.05); prefrontal corpus callosum maximum with white matter volume (P = 0.02); premotor corpus callosum mean with total brain volume (P = 0.04) and white matter volume (P = 0.02), premotor corpus callosum maximum with white matter volume (P = 0.02) and sensory corpus callosum mean with total brain volume (P = 0.02). CONCLUSION: Corpus callosum thickness correlates with brain volume both in HIV-infected patients and controls.
BACKGROUND: Corpus callosum thickness measurement on mid-sagittal MRI may be a surrogate marker of brain volume. This is important for evaluation of diseases causing brain volume gain or loss, such as HIV-related brain disease and HIV encephalopathy. OBJECTIVE: To determine if thickness of the corpus callosum on mid-sagittal MRI is a surrogate marker of brain volume in children with HIV-related brain disease and in controls without HIV. MATERIALS AND METHODS: A retrospective MRI analysis in children (<5 years old) with HIV-related brain disease and controls used a custom-developed semi-automated tool, which divided the midline corpus callosum and measured its thickness in multiple locations. Brain volume was determined using volumetric analysis. Overall corpus callosum thickness and thickness of segments of the corpus callosum were correlated with overall and segmented (grey and white matter) brain volume. RESULTS: Forty-four children (33 HIV-infectedpatients and 11 controls) were included. Significant correlations included overall corpus callosum (mean) and total brain volume (P = 0.05); prefrontal corpus callosum maximum with white matter volume (P = 0.02); premotor corpus callosum mean with total brain volume (P = 0.04) and white matter volume (P = 0.02), premotor corpus callosum maximum with white matter volume (P = 0.02) and sensory corpus callosum mean with total brain volume (P = 0.02). CONCLUSION: Corpus callosum thickness correlates with brain volume both in HIV-infectedpatients and controls.
Authors: René Westerhausen; Eileen Luders; Karsten Specht; Sonja H Ofte; Arthur W Toga; Paul M Thompson; Turid Helland; Kenneth Hugdahl Journal: Cereb Cortex Date: 2010-09-16 Impact factor: 5.357
Authors: Manisha C Shanbhag; Richard M Rutstein; Theoklis Zaoutis; Huaqing Zhao; David Chao; Jerilynn Radcliffe Journal: Arch Pediatr Adolesc Med Date: 2005-07
Authors: M M Thurnher; E G Schindler; S A Thurnher; H Pernerstorfer-Schön; C Kleibl-Popov; A Rieger Journal: AJNR Am J Neuroradiol Date: 2000-04 Impact factor: 3.825
Authors: Eileen Luders; Paul M Thompson; Katherine L Narr; Alen Zamanyan; Yi-Yu Chou; Boris Gutman; Ivo D Dinov; Arthur W Toga Journal: Neuroimage Date: 2010-10-13 Impact factor: 6.556
Authors: Karen A Tucker; Kevin R Robertson; Weili Lin; J Keith Smith; Hongyu An; Yasheng Chen; Stephen R Aylward; Colin D Hall Journal: J Neuroimmunol Date: 2004-12 Impact factor: 3.478
Authors: J A Roelants; I V Koning; M M A Raets; S P Willemsen; M H Lequin; R P M Steegers-Theunissen; I K M Reiss; M J Vermeulen; P Govaert; J Dudink Journal: AJNR Am J Neuroradiol Date: 2016-03-17 Impact factor: 3.825
Authors: Emmanuel C Nwosu; Frances C Robertson; Martha J Holmes; Mark F Cotton; Els Dobbels; Francesca Little; Barbara Laughton; Andre van der Kouwe; Ernesta M Meintjes Journal: Metab Brain Dis Date: 2017-12-05 Impact factor: 3.584
Authors: C Ackermann; S Andronikou; M G Saleh; B Laughton; A A Alhamud; A van der Kouwe; M Kidd; M F Cotton; E M Meintjes Journal: AJNR Am J Neuroradiol Date: 2016-08-18 Impact factor: 3.825
Authors: Susan J van Rensburg; Coenraad Hattingh; Clint Johannes; Kelebogile E Moremi; Armand V Peeters; Carel J van Heerden; Rajiv T Erasmus; Annalise E Zemlin; Merlisa C Kemp; Mariaan Jaftha; Aye Aye Khine; Felix C V Potocnik; Lindiwe Whati; Penelope Engel-Hills; Ronald van Toorn; Maritha J Kotze Journal: Metab Brain Dis Date: 2021-03-12 Impact factor: 3.584
Authors: Peter Ferrazzano; Benjamin Yeske; Jeanette Mumford; Gregory Kirk; Erin D Bigler; Katherine Bowen; Nicole O'Brien; Bedda Rosario; Sue R Beers; Paul Rathouz; Michael J Bell; Andrew L Alexander Journal: J Neurotrauma Date: 2021-02-24 Impact factor: 4.869
Authors: Beatriz Ruiz-Saez; Manuela Martín-Bejarano García; Ana Martinez de Aragon; Mario Gil-Correa; Helena Melero; Norberto Antonio Malpica; Santiago Jimenez de Ory; Berta Zamora; Sara Guillen; Pablo Rojo; Lola Falcon-Neyra; Alberto Alvarez; Pilar Fernandez; María Luisa Lorente-Jareño; Jose Tomas Ramos; Talía Sainz; Carlos Velo; Maria Luisa Navarro; Maria Isabel Gonzalez-Tomé Journal: Medicine (Baltimore) Date: 2021-04-16 Impact factor: 1.817
Authors: Steven R Randall; Christopher M R Warton; Martha J Holmes; Mark F Cotton; Barbara Laughton; Andre J W van der Kouwe; Ernesta M Meintjes Journal: Front Neuroanat Date: 2017-11-02 Impact factor: 3.856